PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 66 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $164,000 | -2.4% | 23,303 | -2.5% | 0.09% | +335.0% |
| Q4 2019 | $168,000 | +33.3% | 23,900 | +136.6% | 0.02% | +233.3% |
| Q1 2019 | $126,000 | -80.2% | 10,100 | -89.3% | 0.01% | -86.4% |
| Q4 2018 | $636,000 | -55.5% | 94,600 | -31.8% | 0.04% | -46.3% |
| Q3 2018 | $1,428,000 | +53.7% | 138,800 | +0.4% | 0.08% | +51.9% |
| Q2 2018 | $929,000 | +32.5% | 138,300 | +69.3% | 0.05% | +20.0% |
| Q1 2018 | $701,000 | +56.8% | 81,700 | +280.0% | 0.04% | +87.5% |
| Q4 2017 | $447,000 | +10.9% | 21,500 | -31.7% | 0.02% | -4.0% |
| Q1 2017 | $403,000 | -41.8% | 31,500 | 0.0% | 0.02% | -56.1% |
| Q4 2016 | $692,000 | -22.2% | 31,500 | -25.2% | 0.06% | -20.8% |
| Q3 2016 | $889,000 | – | 42,100 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $67,646,434 | 21.00% |
| COWEN AND COMPANY, LLC | 1,657,551 | $45,781,558 | 3.80% |
| Kynam Capital Management, LP | 975,298 | $26,937,731 | 3.70% |
| BVF INC/IL | 3,775,900 | $104,290,358 | 2.91% |
| RTW INVESTMENTS, LP | 5,415,514 | $149,576,497 | 2.85% |
| Cormorant Asset Management, LP | 1,500,000 | $41,430,000 | 2.32% |
| Ghost Tree Capital, LLC | 225,000 | $6,214,500 | 2.05% |
| 683 Capital Management, LLC | 814,000 | $22,482,680 | 1.62% |
| Perceptive Advisors | 1,469,761 | $40,594,799 | 1.18% |
| Artia Global Partners LP | 112,340 | $3,102,831 | 1.07% |